Molnupiravir is the first and only capsule against Covid-19 to which the European Medicines Agency has given the green light, but the question now is when it will arrive in Spain.
According to the Ministry of Health, at the moment there is no date set for your arrival, but the European body has already begun to expedite emergency access to this treatment. Our country will join a centralized purchase by the European Union, as it was done with vaccines.
Despite this, this drug is not directed at all patients with Covid-19, only to those who are mild or moderate but who are suspected of having a serious Covid. “Patients with heart disease and diabetes,” says Maricela Valeria, infectious disease specialist at the Gregorio Marañón Hospital in Madrid.
To be effective, it will have to be taken in the first days of infection.. The treatment will be four capsules of 200 milligrams twice a day and it is not necessary to be hospitalized.
In the trials on Molnupiravir in which Gregorio Marañón has participated, it has been shown that it can reduce hospitalization or death by 50% for patients at risk of serious disease.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
